Atlas Trials

Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes

Clinical trial NCT01006291 · COMPLETED

Trial details

NCT number
NCT01006291
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
2009-11-01
Primary completion
2010-09-01
Enrollment
687

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.